Jacob Darlow

发表

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

L. Voltolini, N. Sobhani, A. D’Angelo, 2020, Cancers.

Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study

N. Sobhani, A. D’Angelo, D. Generali, 2022, Current issues in molecular biology.